Abacus Medicine Pharmaceuticals ApS: Financial statements 2019
CVR: 39192063
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -212,160 and a net result of DKK 547,639 compared with DKK 860,434 the year before. Equity in the 2019 report amounted to DKK 15,883,824. The solvency ratio was 70.3%.
- Gross Profit
- DKK -212,160
- Profit/Loss
- DKK 547,639
- Equity
- DKK 15,883,824
- Total Assets
- DKK 22,586,280
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2018. Gross profit came to DKK -61,772, and the net result was DKK 860,434.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Abacus Medicine Pharma Services ApS and Aposave ApS. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity in the 2025 report amounted to DKK 14,264,000.